Intralytix, Inc. is a biotechnology company based in Columbia, MD, specializing in the development of bacteriophage-based solutions for various applications, particularly in food safety and human health. The company focuses on harnessing the natural ability of bacteriophages to target and eliminate specific bacterial pathogens, offering innovative alternatives to traditional antibiotics and chemical preservatives. Intralytix aims to address critical challenges in microbial control through its advanced research and technology in phage therapy and biocontrol.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

17 Patents

#26 in Columbia, MD

#262 in Maryland

#18,894 in US

#35,918 in the World

Columbia, MD, United States of America

Intralytix, Inc.

Forward Citations = 316

8 inventors:

Alexander Sulakvelidze (15 out of 18 patents)

Gary R Pasternack (15 out of 31 patents)

Zemphira Alavidze (4 out of 5 patents)

4. J Glenn Morris (3 out of 7 patents)

5. Torrey C Brown (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Intralytix, Inc.. Retrieved from https://idiyas.com/company/intralytix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]